IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Aug 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-08-05

Reporting Person: MCKEON BRIAN P (Executive VP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-05	Common Stock	M	192	—	Acquired	26403.6426	Direct
2021-08-05	Common Stock	F	96	$705.76	Disposed	26307.6426	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-05	Restricted Stock Unit	$	M	192	Disposed		Common Stock (192)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	18050	Indirect

Footnotes

F1: Includes a total of 23.6426 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020.

F3: Not applicable.